Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid dose-dependently reduce fasting serum triglycerides.
Abstract
The objectives of this review were to determine whether the long-chain omega-3 fatty acids eicosapentaenoic acid and/or docosahexaenoic acid dose-dependently reduce fasting serum triglycerides (TG) and, if so, to create a mathematical model that may be used to predict potential percent reductions in fasting serum TG levels at the recommended intakes of 200-500 mg/day. The assessment included 15 randomized controlled trials that met pre-defined inclusion and exclusion criteria. Across these 15 studies, the dose-response was modeled using a first-order elimination curve. The response variable was defined as percent change from baseline in fasting serum TG, adjusted for the placebo effect. A weighting factor equal to the product of each study's sample size and quality score was used. Using the equation of the dose-response curve, predicted reductions in fasting serum TG levels at the recommended long-chain omega-3 fatty acid intakes of 200-500 mg/day are 3.1 to 7.2%.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Approximately 3 to 4 g/d of EPA plus DHA are necessary to reduce hypertriglyceridemia by 20-50%.
“Approximately 3 to 4 g/d of EPA plus DHA are necessary to reduce hypertriglyceridemia by 20 -50% (179).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [179]
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works
Who, J., & Diet, N. F. E. C. O. (2003) · World Health Organization eBooks · Cited by 3,425 · see citing works
De Backer, G. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00347-6 · Cited by 2,251 · see citing works
Omega-3 fatty acids in health and disease and in growth and development.
Simopoulos, A. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.3.438 · Cited by 2,162 · see citing works
Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706 · see citing works
Management of acute myocardial infarction in patients presenting with ST-segment elevation
de Werf, F. V. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00618-8 · Cited by 1,441 · see citing works
EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE
Backer, D. D., Амбросиони, Е., Borch‐Johnsen, K., Brotons, C., Cífková, R., Dallongeville, J., Ebrahim, S. B. J., Færgeman, O., Graham, I. D., Mancia, G., et al. (2005) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2005-1-3-57-65 · Cited by 1,268 · see citing works
n-3 fatty acids and serum lipoproteins: human studies
Harris, W. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1645s · Cited by 1,243 · see citing works
Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review
Harris, W. S. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38310-3 · Cited by 1,127 · see citing works
Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review
Balk, E. M., Lichtenstein, A. H., Chung, M., Kupelnick, B., Chew, P., & Lau, J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.012 · Cited by 732 · see citing works
Triglyceride Concentration and Ischemic Heart Disease
Jeppesen, J., Hein, H. O., Suadicani, P., & Gyntelberg, F. (1998) · Circulation · doi:10.1161/01.cir.97.11.1029 · Cited by 673 · see citing works
European guidelines on cardiovascular disease prevention in clinical practice
Backer, G. D., Ambrosioni, E., Borch‐Johnsen, K., Brotons, C., Cífková, R., Dallongeville, J., Ebrahim, S. B. J., Færgeman, O., Graham, I. D., Mancia, G., et al. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.10.001 · Cited by 493 · see citing works
Summary of American Heart Association Diet and Lifestyle Recommendations Revision 2006
Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000238352.25222.5e · Cited by 345 · see citing works
Safety and Efficacy of Omacor in Severe Hypertriglyceridemia
Harris, W. S., Ginsberg, H. N., Arunakul, N., Shachter, N. S., Windsor, S. L., Adams, M., Berglund, L., & Osmundsen, K. (1997) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679700400511 · Cited by 306 · see citing works
Fish oil and glycemic control in diabetes. A meta-analysis.
Friedberg, C. E., Janssen, M. J. F. M., Heine, R. J., & Grobbee, D. E. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.494 · Cited by 303 · see citing works
Safety and efficacy of Omacor in severe hypertriglyceridemia
Harris, W. S., Ginsberg, H. N., Arunakul, N., Shachter, N. S., Windsor, S. L., Adams, M., Berglund, L., & Osmundsen, K. (1997) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199710000-00011 · Cited by 252 · see citing works
Hill, A. M., Buckley, J. D., Murphy, K. J., & Howe, P. R. C. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.5.1267 · Cited by 237 · see citing works
Managing Abnormal Blood Lipids
Fletcher, B. J., Berra, K. A., Ades, P., Braun, L. T., Burke, L. E., Durstine, J. L., Fair, J. M., Fletcher, G. F., Goff, D. C., Hayman, L. L., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169180 · Cited by 236 · see citing works
Enriched Eggs as a Source of N-3 Polyunsaturated Fatty Acids for Humans
Lewis, N. M., SEBURG, S., & Flanagan, N. (2000) · Poultry Science · doi:10.1093/ps/79.7.971 · Cited by 200 · see citing works
Stark, K. D., & Holub, B. J. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.5.765 · Cited by 177 · see citing works
Browning, L. M., Krebs, J. D., Moore, C. S., Mishra, G. D., O’Connell, M. A., & Jebb, S. A. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00576.x · Cited by 162 · see citing works
Role of n−3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease
Jacobson, T. A. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.6.1981s · Cited by 147 · see citing works
CONNOR, W. E., DeFRANCESCO, C. A., & CONNOR, S. L. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb35689.x · Cited by 119 · see citing works
Buckley, R., Shewring, B., Turner, R., Yaqoob, P., & Minihane, A. M. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041235 · Cited by 118 · see citing works
Dyerberg, J., Eskesen, D. C., Andersen, P. W., Astrup, A. V., Buemann, B., Christensen, J., Clausen, P., Rasmussen, B. F., Schmidt, E. B., Tholstrup, T., et al. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601934 · Cited by 117 · see citing works
Murphy, K. J., Meyer, B. J., Mori, T. A., Burke, V., Mansour, J., Patch, C. S., Tapsell, L. C., Noakes, M., Clifton, P. A., Barden, A., et al. (2007) · British Journal Of Nutrition · doi:10.1017/s000711450747252x · Cited by 110 · see citing works
Leigh-Firbank, E. C., Minihane, A. M., Leake, D. S., Wright, J. W., Murphy, M. C., Griffin, B. A., & Williams, C. M. (2002) · British Journal Of Nutrition · doi:10.1079/bjn2002556 · Cited by 108 · see citing works
Triglyceride-lowering effect of omega-3 LC-polyunsaturated fatty acids--a review.
Weber, P., & Raederstorff, D. (2000) · PubMed · Cited by 106 · see citing works
New and classical risk factors--the Münster heart study (PROCAM).
Assmann, G., Schulte, H., & Cullen, P. (1997) · PubMed · Cited by 105 · see citing works
Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia
Skulas-Ray, A. C., West, S. G., Davidson, M. H., & Kris-Etherton, P. M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.7.1237 · Cited by 91 · see citing works
Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity
Chan, D. C., Watts, G. F., Mori, T. A., Barrett, P. H. R., Beilin, L. J., & Redgrave, T. G. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01001.x · Cited by 90 · see citing works
Lovegrove, J. A., Lovegrove, S. S., Lesauvage, S. V., Brady, L. M., Saini, N., Minihane, A. M., & Williams, C. M. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.6.974 · Cited by 88 · see citing works
Diurnal triglyceride profiles: a novel approach to study triglyceride changes
Cabezas, M. C., Halkes, C. J. M., Meijssen, S., van Oostrom, A. J. H. H. M., & Erkelens, D. W. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00554-2 · Cited by 75 · see citing works
Ryan, A. S., Keske, M. A., Hoffman, J. P., & Nelson, E. B. (2009) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31817fe2be · Cited by 72 · see citing works
Wu, W. H., Lu, S. C., Wang, T. F., Jou, H. J., & Wang, T. A. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602328 · Cited by 70 · see citing works
Maki, K. C., Elswyk, M. E. V., McCarthy, D., Hess, S. P., Veith, P. E., Bell, M., Subbaiah, P. V., & Davidson, M. H. (2005) · Journal of the American College of Nutrition · doi:10.1080/07315724.2005.10719465 · Cited by 67 · see citing works
Goyens, P. L. L., & Mensink, R. P. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602408 · Cited by 62 · see citing works
Cholesterol and triglyceride concentrations in serum/plasma pairs.
(1977) · Clinical Chemistry · doi:10.1093/clinchem/23.1.60 · Cited by 59 · see citing works
Buttriss, J. (1999) · Nutrition Bulletin · doi:10.1111/j.1467-3010.1999.tb00884.x · Cited by 53 · see citing works
Maki, Elswyk, V., McCarthy, Seeley, Veith, Hess, Ingram, I., Halvorson, Calaguas, & Davidson (2003) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831.73.5.357 · Cited by 47 · see citing works
Extending the cardiovascular benefits of omega-3 fatty acids
Harris, W. S. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0050-0 · Cited by 46 · see citing works
A surveillance study of escitalopram treatment of depressed patients
Anders, M., Tuma, I., & Rösslerova, H. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.1.1 · Cited by 44 · see citing works
Liu, M., Wallin, R., & Saldeen, T. G. P. (2001) · Nutrition Research · doi:10.1016/s0271-5317(01)00353-0 · Cited by 42 · see citing works
n−3 long‐chain FA decrease serum levels of TG and remnant‐like particle‐cholesterol in humans
Hamazaki, K., Itomura, M., Huan, M., Nishizawa, H., Watanabe, S., Hamazaki, T., Sawazaki, S., TERASAWA, K., Nakajima, S., Terano, T., et al. (2003) · Lipids · doi:10.1007/s11745-003-1069-x · Cited by 41 · see citing works
Saldeen, T. G. P., Wallin, R., & Marklinder, I. (1998) · Nutrition Research · doi:10.1016/s0271-5317(98)00124-9 · Cited by 34 · see citing works
(2000) · Nutrition Bulletin · doi:10.1046/j.1467-3010.2000.00013.x · Cited by 23 · see citing works
de Castro, I. A., Monteiro, V. C. B., Barroso, L. P., & Bertolami, M. C. (2007) · Nutrition · doi:10.1016/j.nut.2006.11.006 · Cited by 19 · see citing works
Dose-Response Relationships in Blood Lipids during Moderate Freshwater Fish Diet
Hänninen, O., Agren, J. J., Laitinen, M. V., et al. (1989) · Annals of Medicine · doi:10.3109/07853898909149934 · Cited by 13 · see citing works
Baker, S. J., & Al‐Najadah, R. (1996) · Sports medicine, training, and rehabilitation/Sports medicine, training and rehabilitation · doi:10.1080/15438629609512059 · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887 · see citing works
“Approximately 3 to 4 g/d of EPA plus DHA are necessary to reduce hypertriglyceridemia by 20–50% (179).”
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784 · see citing works
Bays, H. E., Ballantyne, C. M., Kastelein, J. J., Isaacsohn, J. L., Braeckman, R. A., & Soni, P. N. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.04.015 · Cited by 358 · see citing works
Fish oil — How does it reduce plasma triglycerides?
Shearer, G. C., Savinova, O. V., & Harris, W. S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.011 · Cited by 285 · see citing works
Kastelein, J. J. P., Maki, K. C., Susekov, A., Ezhov, M., Nordestgaard, B. G., Machielse, B. N., Kling, D., & Davidson, M. H. (2014) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.10.003 · Cited by 233 · see citing works
Walker, C. G., Jebb, S. A., & Calder, P. C. (2013) · Nutrition · doi:10.1016/j.nut.2012.06.003 · Cited by 91 · see citing works
Maki, K. C., Bays, H. E., & Dicklin, M. R. (2012) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2012.04.003 · Cited by 83 · see citing works
EFSA Panel on Dietetic Products, N. A. A. (. (2010) · EFSA Journal · doi:10.2903/j.efsa.2010.1796 · Cited by 65 · see citing works
Schmidt, S., Willers, J., Stahl, F., Mutz, K.-O., Scheper, T., Hahn, A., & Schuchardt, J. P. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-172 · Cited by 31 · see citing works
- Authors
- Musa-Veloso, K., Binns, M. A., Kocenas, A. C., Poon, T., Elliot, J. A., Rice, H., Oppedal-Olsen, H., Lloyd, H., & Lemke, S.
- Affiliations
- University of Toronto (CA)
- Cantox Health Sciences International (CA)
- Monsanto (United States) (US)
- Venue
- Nutrition Reviews
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-03
- Volume
- 68
- Issue
- 3
- Pages
- 155-167
- ISSN
- 0029-6643 (ISSN-L)
- 1753-4887
- OpenAlex
- W2170485201
- Cited by
- 73
- References
- 49
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 4 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 2 · 2016: 6 · 2015: 12 · 2014: 5 · 2013: 10 · 2012: 10
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nutrition Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cargill
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Aquaculture Nutrition and Growth
- Physical Sciences › Chemistry › Organic Chemistry › Edible Oils Quality and Analysis
- Keywords
- eicosapentaenoic acid, docosahexaenoic acid, n-3 long-chain polyunsaturated fatty acids, serum triglycerides, fasting triglycerides, dose-response relationship, mathematical modeling, dietary supplementation
- MeSH terms
- Docosahexaenoic Acids, Dose-Response Relationship, Drug, Fasting, Humans, Triglycerides, Eicosapentaenoic Acid, Randomized Controlled Trials as Topic, Nutrition Policy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review